NRNP 6557 Week 11 Reflection Example

Reflection: From Ranking by Threat to Ranking by What Forecloses the Next Decision

Student Name

College of Nursing, Walden University

NRNP 6557: Adult Acute Care: Comprehensive Patient Management II

Instructor Name

Month Day, Year

Reflection: From Ranking by Threat to Ranking by What Forecloses the Next Decision

The Early Reasoning, Reproduced

In the week 2 problem list for the man with ulcer bleeding and a five-week-old stent, I justified putting the ulcer first, in close paraphrase, by saying that a rebleed within three days would endanger him sooner than anything else on his list, and that no other problem could be handled safely until the bleeding was under control. The ranking principle in that justification is threat: which problem is most dangerous, soonest. It was supported by evidence that most rebleeding after endoscopic therapy occurs in the first three days (Lau et al., 2000), and it was not wrong. I would write the same entry again today; what has changed is what I would write beneath it.

The Reasoning Now

By the week 10 presentation, I was ranking differently. The decision there was whether to switch his ticagrelor to clopidogrel, and the finding that decided it was not the most dangerous one on the list. It was that he could not afford the copay. I ranked the affordability problem above the pharmacology because it was the problem most likely to close off every other option: if he stopped taking his P2Y12 inhibitor altogether, the careful comparison of ticagrelor and clopidogrel would no longer matter. The principle had shifted from which problem is most dangerous to which problem, left alone, removes the ability to manage the others.

Naming the Difference

Threat ranking asks what will hurt the patient first. Foreclosure ranking asks what will take away the next decision. They often agree, as they did in week 2, when uncontrolled bleeding both threatened him and would have forced a longer, less controlled interruption of his antiplatelet drugs. They diverge when a less dangerous problem can make a more dangerous one unmanageable, and in acute care those problems are often not clinical at all, such as a copay, a pharmacy that is 40 minutes away, or an appointment that the clinic cannot schedule for six weeks.

What Caused It

Three assignments moved me. The first was the week 6 analysis of the type 2 infarction. Writing the earlier-signal section, I found that the heart rate drift from 88 to 104 had been visible for 14 hours; it did not threaten him on its own, but it foreclosed the chance to transfuse before ischemia began. That was the first time I saw a low-threat finding outrank a high-threat one in hindsight.

The second was the week 8 discussion on deferred problems, where I set my restart triggers for lisinopril in advance. Writing a trigger forced me to ask what would make the deferral impossible to maintain, not just what would make the drug more useful. I had done the same thing without naming it in week 4, when I set active ischemia as the flip condition for the transfusion threshold, and that condition fired on day 3; the liberal threshold it switched to rests on the MINT results in patients with infarction and anemia (Carson et al., 2023).

The third was the week 9 transition plan. Naming a single point of failure required me to look for the problem that would undo the others, and it turned out to be ticagrelor adherence, not the ulcer. Transition research had told me that coaching patients to take an active role reduces rehospitalization (Coleman et al., 2006), but writing the plan showed me why: the weak links are practical, and they are found only by asking about them.

What Did Not Change

My first pass at any list is still a threat ranking. When I opened the week 9 plan, I began with the ulcer and the stent and reached the copay only on the third revision. I have not yet learned to ask the foreclosure question at the start rather than after the clinical problems are settled. I also still find it hard to state a threshold where the literature does not give one: in week 8 I wrote that my systolic trigger of 160 was my own judgment, and I am not confident it was the right number. I would rather have left it out, which is the habit the course was trying to break.

In practice, I plan to add one question to every problem list I write: which entry, if it fails, takes the others with it? I expect the answer to be clinical most of the time, and when it is not, that is where the plan is most likely to break.

References

Carson, J. L., Brooks, M. M., Hébert, P. C., Goodman, S. G., Bertolet, M., Glynn, S. A., Chaitman, B. R., Simon, T., Lopes, R. D., Goldsweig, A. M., DeFilippis, A. P., Abbott, J. D., Potter, B. J., Carrier, F. M., Rao, S. V., Cooper, H. A., Ghafghazi, S., Fergusson, D. A., Kostis, W. J., . . . Alexander, J. H. (2023). Restrictive or liberal transfusion strategy in myocardial infarction and anemia. The New England Journal of Medicine, 389(26), 2446-2456. https://doi.org/10.1056/NEJMoa2307983

Coleman, E. A., Parry, C., Chalmers, S., & Min, S.-J. (2006). The care transitions intervention: Results of a randomized controlled trial. Archives of Internal Medicine, 166(17), 1822-1828. https://doi.org/10.1001/archinte.166.17.1822

Lau, J. Y., Sung, J. J., Lee, K. K., Yung, M. Y., Wong, S. K., Wu, J. C., Chan, F. K., Ng, E. K., You, J. H., Lee, C. W., Chan, A. C., & Chung, S. C. (2000). Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. The New England Journal of Medicine, 343(5), 310-316. https://doi.org/10.1056/NEJM200008033430501